Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lichter

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
British Journal of Clinical Pharmacology|June 1, 1986
Differential effects of atenolol and enalapril on memory during treatment for essential hypertensionI Lichter, P J Richardson, M A Wyke
Thorax|October 1, 1976
Localized pulmonary Wegener's granuloma simulating lung cancer: report of four casesJ B Blennerhassett, J Borrie, I Lichter, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|October 1, 2010
Where do they come from and where do they go: implications of geographic origins of medical studentsRichard W Pretorius, Michael I Lichter, Goroh Okazaki, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|January 13, 2012
The adoption and use of health information technology in rural areas: results of a national surveyRanjit Singh, Michael I Lichter, Andrew Danzo, et al.
Molecular Cancer|April 21, 2012
Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell linesErika von Euw, Mohammad Atefi, Narsis Attar, et al.
Blood|September 29, 2012
Sequence analysis of β-subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasoneDavid I Lichter, Hadi Danaee, Michael D Pickard, et al.
Gastroenterology|August 9, 2020
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative ColitisMatthew R Henn, Edward J O'Brien, Liyang Diao, et al.
Blood|December 17, 2013
Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapyGeorge Mulligan, David I Lichter, Alessandra Di Bacco, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
British Journal of Clinical Pharmacology|June 1, 1986
Differential effects of atenolol and enalapril on memory during treatment for essential hypertensionI Lichter, P J Richardson, M A Wyke
Thorax|October 1, 1976
Localized pulmonary Wegener's granuloma simulating lung cancer: report of four casesJ B Blennerhassett, J Borrie, I Lichter, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|October 1, 2010
Where do they come from and where do they go: implications of geographic origins of medical studentsRichard W Pretorius, Michael I Lichter, Goroh Okazaki, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|January 13, 2012
The adoption and use of health information technology in rural areas: results of a national surveyRanjit Singh, Michael I Lichter, Andrew Danzo, et al.
Molecular Cancer|April 21, 2012
Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell linesErika von Euw, Mohammad Atefi, Narsis Attar, et al.
Blood|September 29, 2012
Sequence analysis of β-subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasoneDavid I Lichter, Hadi Danaee, Michael D Pickard, et al.
Gastroenterology|August 9, 2020
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative ColitisMatthew R Henn, Edward J O'Brien, Liyang Diao, et al.
Blood|December 17, 2013
Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapyGeorge Mulligan, David I Lichter, Alessandra Di Bacco, et al.
Pageof 3